Related Experiment Video

Updated: Jul 20, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Genetic induction of tumorigenesis in swine

S J Adam1, L A Rund, K N Kuzmuk

  • 1Department of Pharmacology and Cancer Biology, Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Oncogene
|September 12, 2006
PubMed

Insights

Researchers created a new large animal cancer model using genetically engineered pigs. This model allows for the rapid and reproducible development of tumors, aiding preclinical cancer research and therapeutic development.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Transitioning experimental cancer therapeutics to clinical trials requires effective large animal models.
  • Current models lack genetic malleability and reproducibility for preclinical studies.

Purpose of the Study:

  • To develop a genetically engineered large animal model for cancer research.
  • To create a robust platform for preclinical testing of cancer therapeutics.

Main Methods:

  • Genetically engineered primary porcine cells to express proteins that disrupt cancer-related pathways.
  • Induced tumorigenicity in porcine cells, mimicking human cancer development.
  • Transplanted engineered cells into isogenic host animals to form tumors.

Main Results:

  • Engineered porcine cells exhibited resistance to transformation, requiring multiple genetic modifications.
  • Transformed porcine cells successfully formed tumors in host animals.
  • The model allows for reproducible tumor generation in a large mammal relevant to human physiology.

Conclusions:

  • A genetically engineered porcine model provides a valuable tool for preclinical cancer research.
  • This model facilitates the study of experimental therapeutics in a clinically relevant setting.
  • The ability to rapidly induce tumors aids in advancing cancer drug development.

More Related Videos

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...